2
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Estimating an EQ-5D-Y-3L Value Set for China

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Introduction

          The standard EQ-5D-Y-3L valuation protocol applies DCE data as the primary preference source to model the relative importance of dimensions while cTTO data served to anchor the DCE coefficients onto the QALY scale. This study aims to estimate an EQ-5D-Y-3L value set for China following this protocol, but with a larger cTTO design to better understand the role of cTTO data in estimating EQ-5D-Y-3L value sets.

          Methods

          In total, 150 choice sets and 28 EQ-5D-Y-3L health states were valued using DCE and cTTO methods with two independent samples, respectively. General public from 14 different regions were recruited using quota sampling method to achieve representativeness. We compared two modelling strategies: (1) fit the DCE data with mixed logit model with correlated coefficients and a subsequent mapping procedure for anchoring; (2) fit the DCE and TTO data jointly in a hybrid model. Two evaluation criteria (1) coefficient significance and monotonicity; (2) prediction accuracy of the observed cTTO values were used to select the value set.

          Results

          In total, 1476 individuals participated in the study, with 1058 participated the DCE interview and 418 participated the cTTO interview. The highest mean TTO value was 0.924 for state 11112 and the lowest mean TTO value was − 0.088 for state 33333. The hybrid model with an A3 term performed the best and was selected as the value set.

          Discussion

          Following the international protocol and using a larger cTTO design, this study established the EQ-5D-Y-3L value set using a hybrid model for China. Future EQ-5D-Y-3L valuation study could consider using a larger cTTO design for estimating the value set.

          Supplementary Information

          The online version contains supplementary material available at 10.1007/s40273-022-01216-9.

          Related collections

          Most cited references43

          • Record: found
          • Abstract: found
          • Article: not found
          Is Open Access

          Dutch Tariff for the Five-Level Version of EQ-5D.

          In 2009, a new version of the EuroQol five-dimensional questionnaire (EQ-5D) was introduced with five rather than three answer levels per dimension. This instrument is known as the EQ-5D-5L. To make the EQ-5D-5L suitable for use in economic evaluations, societal values need to be attached to all 3125 health states.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Estimating an EQ-5D-5L Value Set for China.

            To estimate a five-level EuroQol five-dimensional questionnaire (EQ-5D-5L) value set for China using the health preferences of residents living in the urban areas of the country.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Development of the EQ-5D-Y: a child-friendly version of the EQ-5D

              Purpose To develop a self-report version of the EQ-5D for younger respondents, named the EQ-5D-Y (Youth); to test its comprehensibility for children and adolescents and to compare results obtained using the standard adult EQ-5D and the EQ-5D-Y. Methods An international task force revised the content of EQ-5D and wording to ensure relevance and clarity for young respondents. Children’s and adolescents’ understanding of the EQ-5D-Y was tested in cognitive interviews after the instrument was translated into German, Italian, Spanish and Swedish. Differences between the EQ-5D and the EQ-5D-Y regarding frequencies of reported problems were investigated in Germany, Spain and South Africa. Results The content of the EQ-5D dimensions proved to be appropriate for the measurement of HRQOL in young respondents. The wording of the questionnaire had to be adapted which led to small changes in the meaning of some items and answer options. The adapted EQ-5D-Y was satisfactorily understood by children and adolescents in different countries. It was better accepted and proved more feasible than the EQ-5D. The administration of the EQ-5D and of the EQ-5D-Y causes differences in frequencies of reported problems. Conclusions The newly developed EQ-5D-Y is a useful tool to measure HRQOL in young people in an age-appropriate manner.
                Bookmark

                Author and article information

                Contributors
                Zhihao_yang_cn@126.com
                Journal
                Pharmacoeconomics
                Pharmacoeconomics
                Pharmacoeconomics
                Springer International Publishing (Cham )
                1170-7690
                1179-2027
                18 November 2022
                18 November 2022
                2022
                : 40
                : Suppl 2
                : 147-155
                Affiliations
                [1 ]GRID grid.413458.f, ISNI 0000 0000 9330 9891, Health Services Management Department, , Guizhou Medical University, ; Gui’an, China
                [2 ]GRID grid.258164.c, ISNI 0000 0004 1790 3548, College of Pharmacy, , Jinan University, ; Guangzhou, China
                [3 ]GRID grid.8547.e, ISNI 0000 0001 0125 2443, School of Public Health, , Fudan University, ; Shanghai, China
                [4 ]GRID grid.24695.3c, ISNI 0000 0001 1431 9176, Centre for Evidence-Based Chinese Medicine, , Beijing University of Chinese Medicine, ; Beijing, China
                [5 ]GRID grid.33763.32, ISNI 0000 0004 1761 2484, School of Pharmaceutical Science and Technology, , Tianjin University, ; Tianjin, China
                [6 ]GRID grid.43169.39, ISNI 0000 0001 0599 1243, Department of Pharmacy Administration, School of Pharmacy, Health Science Centre, , Xi’an Jiaotong University, ; Xi’an, China
                [7 ]GRID grid.33199.31, ISNI 0000 0004 0368 7223, School of Pharmacy, Tongji Medical College, , Huazhong University of Science and Technology, ; Wuhan, China
                [8 ]GRID grid.254147.1, ISNI 0000 0000 9776 7793, The Research Centre of National Drug Policy and Ecosystem, , China Pharmaceutical University, ; Nanjing, China
                [9 ]GRID grid.27255.37, ISNI 0000 0004 1761 1174, Centre for Health Management and Policy Research, School of Public Health, Cheeloo College of Medicine, , Shandong University, ; Jinan, China
                [10 ]GRID grid.411680.a, ISNI 0000 0001 0514 4044, Department of Preventive Medicine, , Medical College of Shihezi University, ; Shihezi, China
                [11 ]GRID grid.411176.4, ISNI 0000 0004 1758 0478, Department of Pharmacy, , Fujian Medical University Union Hospital, ; Fuzhou, China
                [12 ]GRID grid.410736.7, ISNI 0000 0001 2204 9268, School of Health Management, , Harbin Medical University, ; Harbin, China
                [13 ]GRID grid.4280.e, ISNI 0000 0001 2180 6431, Saw Swee Hock School of Public Health, , National University of Singapore, ; Singapore, Singapore
                Author information
                http://orcid.org/0000-0001-5468-0847
                Article
                1216
                10.1007/s40273-022-01216-9
                9758244
                36396878
                f9276e16-8ec2-4e35-b285-9e366f88e2b6
                © The Author(s) 2022

                Open AccessThis article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/.

                History
                : 1 November 2022
                Funding
                Funded by: FundRef http://dx.doi.org/10.13039/501100006419, EuroQol Research Foundation;
                Award ID: 20191020
                Award Recipient :
                Categories
                Original Research Article
                Custom metadata
                © Springer Nature Switzerland AG 2022

                Economics of health & social care
                Economics of health & social care

                Comments

                Comment on this article